Pulte Group Onc: (NYSE: PHM)
$24.25
0.86 (3.68%)
Volume 7,747,575
May 14 04:03 PM ET
Zacks Rank: 3-Hold 
| #3 |
Brokerage Recommendations
| Current ABR | 2.33 |
| ABR (Last week) | 2.33 |
| # of Recs in ABR | 15 |
| Average Target Price | $22.25 |
| LT Growth Rate | 10.00% |
| Industry | BLDG-RSDNT/COMR |
| Industry Rank by ABR | 13 of 265 |
| Current Quarter EPS Est: | 0.27 |
Premium research
Zacks Rank
|
 3 |
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
13 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Brokerage Recommendations
| Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|---|
| Strong Buy | 5.00 | 5.00 | 4.00 | 4.00 | 3.00 |
| Buy | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 |
| Hold | 7.00 | 7.00 | 7.00 | 6.00 | 6.00 |
| Sell | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Strong Sell | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| ABR | 2.33 | 2.33 | 2.40 | 2.36 | 2.46 |
Analyst Upgrades/Downgrades
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
